Skip to content

The Effects of Auriculotherapy in Women With Breast Cancer During Chemotherapy Treatment

The effects of auriculotherapy in women with breast cancer undergoing chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-36zcfg
Enrollment
Unknown
Registered
2018-01-08
Start date
2017-03-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women

Interventions

Intervention group - Application of auriculotherapy in 33 women with breast cancer who are receiving chemotherapy treatment. Crystal beads will be applied to six auricular points Using the dotting pen
Other
E02.190.044.133
E05.318.308.980

Sponsors

Hospital de Clinicas da Universidade Federal do Paraná
Lead Sponsor
Hospital de Clinicas da Universidade Federal do Paraná
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women; Diagnosis of breast cancer; Chemotherapy treatment; Age between 18 and 99 years

Exclusion criteria

Exclusion criteria: Using anxiolytics; Antidepressants; Pregnant women

Design outcomes

Primary

MeasureTime frame
Based on previous studies (CREW et al, 2007), it is expected that 60% of the patients participating in the study will show improvement in cancer-related symptoms and chemotherapy treatment and consequent improvement in Quality of Life measured by the Quality Assessment Questionnaire called EORT-QLQ-30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) version 3.0.

Secondary

MeasureTime frame
Based on the same study mentioned above, it is expected an improvement in social well-being of 10%, an improvement of the emotional function of 40% and functional function of 20%, measured by the Quality of Life evaluation questionnaire called EORT-QLQ-30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire) version 3.0.

Countries

Brazil

Contacts

Public ContactElizabeth Tischenberg Aguiar Vallim

Hospital de Clinicas da Universidade Federal do Paraná

elizabethvallim@gmail.com+55 (41) 3360 1800

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 22, 2026